Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02191969 · ClinicalTrials.gov registry record · NA

Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer

A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT02191969: Completed NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT02191969 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02191969, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

This study will see if patient who undergo a physical activity intervention called Walk With Ease report experiencing less fatigue and a higher quality of life during chemotherapy for colorectal cancer than those who do not participate in this intervention.

Primary Outcome

The investigators will compare the change in fatigue from baseline to 3 months between Intervention and Control arms as measured via PROMIS®-Fatigue.

Interventions

  • BEHAVIORAL Walk With Ease

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2014-06
Est. Completion 2019-09-18
Phase NA

What the finished NCT02191969 record still lists

NCT02191969 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Walk With Ease is the first listed.

NCT02191969 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02191969 about?

NCT02191969 is a clinical study titled "Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer". This study will see if patient who undergo a physical activity intervention called Walk With Ease report experiencing less fatigue and a higher quality of life during chemotherapy for colorectal cancer than those who do not participate in this intervention.

What is the current status of trial NCT02191969?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2014-06. Estimated completion is 2019-09-18.

What interventions are being tested in trial NCT02191969?

The interventions under investigation include: Walk With Ease (BEHAVIORAL).

Who is sponsoring clinical trial NCT02191969?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02191969's enrollment target sits among peer trials

36 1541st of 2000 higher than 437 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02191969, the US trial registry maintained by the National Library of Medicine. NCT02191969 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.